Elucent Medical receives over $42 million in funding
Elucent Medical, a medical technology company headquartered in Eden Prairie and focused on the field of surgical navigation, recently successfully completed a $42.5 million Series C funding round. The funding, led by Vensana Capital and...
Elucent Medical receives over $42 million in funding
Elucent Medical, a medical technology company headquartered in Eden Prairie and focused on the field of surgical navigation, recently successfully completed a $42.5 million...
Molli Surgical launches OncoPen 3D image guidance wand for breast cancer
Molli Surgical launched its OncoPen surgical tool for breast cancer imaging. The sleek, pen-like wand integrates with the Deerfield, Illinois-based company’s Molli 2 system...
Nectero Medical closes $96M Series D
Nectero Medical announced it closed a Series D financing round worth proceeds of $96 million. Norwest Venture Partners led the round. Boston Scientific, BioStar...
Prothea debuts with $13m to develop cancer diagnostics and treatment
The University of Edinburgh and Bath spin-off, Prothea Technologies, has closed €12m ($13m) in Series A financing to develop cancer diagnostics and therapeutics. The company...
[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]
Finance
Clinical Trials
Signati kicks off trial investigating quicker vasectomy device
Signati Medical has enrolled the first patient in a clinical trial investigating its device designed to quicken vasectomy procedures. The trial, operating under an investigative...
Photopharmics kickstarts phototherapy trial for Parkinson’s disease
US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy device. The US Food and...
Novocure’s TTFields device slows metastasis in NSCLC
NovoCure’s Tumor Treating Fields (TTFields) therapy met its primary endpoint in the Phase III METIS trial by slowing the progression of brain metastasis in...
Cleerly touts new data for AI cardiovascular software
Digital healthcare company Cleerly has announced that positive data from two studies investigating its AI-QCT ISCHEMIA software device has been published. Cleerly’s ISCHEMIA software device...
Regulatory Approvals
Elucent Medical receives over $42 million in funding
Elucent Medical, a medical technology company headquartered in Eden Prairie and focused on the field of surgical navigation, recently successfully completed a $42.5 million...
Molli Surgical launches OncoPen 3D image guidance wand for breast cancer
Molli Surgical launched its OncoPen surgical tool for breast cancer imaging. The sleek, pen-like wand integrates with the Deerfield, Illinois-based company’s Molli 2 system...
Nectero Medical closes $96M Series D
Nectero Medical announced it closed a Series D financing round worth proceeds of $96 million. Norwest Venture Partners led the round. Boston Scientific, BioStar...
Prothea debuts with $13m to develop cancer diagnostics and treatment
The University of Edinburgh and Bath spin-off, Prothea Technologies, has closed €12m ($13m) in Series A financing to develop cancer diagnostics and therapeutics. The company...
M&A
Archives
Latest articles